1Pabuccu R,AkarME.Luteal ducetive technology [J]. Curt 277-281. phase support in assisted repro- in Ogster Gynecol, 2005,17 (3):277-281.
2ChakravartyBN,ShirazeeHH,Pam P,et al.Oral hymgesterone versus interavaginal miemnized progesterone as luteal phase sup- port in assisted reprod ucetive technology(ART) cycles: resuits of a randomized study [J].J STERO D Biochem Mol Biol,2005,97 (5):416-420.
8Szekeres-Bartho J,Barakonyi A,Par G,et al.Progesterone as an immunomodulatory molecule[J].Int Immunopharma- col, 2001,1 (6) : 1037-1048.
9Abresch RT,McDonald DA,Widman LM,et d.Impact of spinal cord ,dysfunction and obesity on the health-relat- ed quality of life of children and adolescents [J].J Spinal Cord Med,2007,30(l) : 112-118.
10Duan L, Yan D,Zeng W.Effect of progesterone treatment due to threatened abortion in early pregnancy for obstet- ric and perinatal outcomes[J].Early Hum Dev,2010,86( 1 ) : 41-43.
